Sharda Cropchem Ltd. (IN:SHARDACROP)
:SHARDACROP
Want to see IN:SHARDACROP full AI Analyst Report?
Top Page
Sharda Cropchem Ltd.
(SHARDACROP)
Select Model
Select Model
Rating:73Outperform
Price Target:
₹1,082.00
▲(26.52% Upside)
Action:Reiterated
Date:05/16/26
The score is driven primarily by strong financial performance—especially the very conservative balance sheet and FY2026 profitability recovery with good recent cash conversion. This is partly offset by weaker technicals (trading below key moving averages with soft momentum), while valuation is supportive with a modest P/E and a small dividend yield.
Positive Factors
Conservative balance sheet (effectively no debt)
Effectively zero net debt and very low leverage provide durable financial flexibility across agricultural cycles. This structural strength lowers refinancing and solvency risk, enabling the firm to fund registrations, absorb crop-demand swings, and prioritize capex or dividends without reliance on market funding.
Negative Factors
Cyclical revenue and earnings volatility
Historic sharp swings in revenue and profits reflect agricultural cyclicality and exposure to demand, weather and crop cycles. This structural volatility complicates forecasting, capital allocation and margin sustainability over 2–6 months, and raises the risk of future earnings reversals.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet (effectively no debt)
Effectively zero net debt and very low leverage provide durable financial flexibility across agricultural cycles. This structural strength lowers refinancing and solvency risk, enabling the firm to fund registrations, absorb crop-demand swings, and prioritize capex or dividends without reliance on market funding.
Read all positive factors
Sharda Cropchem Ltd. (SHARDACROP) vs. iShares MSCI India ETF (INDA)
Market Cap
₹80.41B
Dividend Yield1.02%
Average Volume (3M)9.90K
Price to Earnings (P/E)11.5
Beta (1Y)1.92
Revenue Growth21.94%
EPS Growth123.70%
CountryIN
Employees500
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)50.09
Shares Outstanding90,220,500
10 Day Avg. Volume7,432
30 Day Avg. Volume9,903
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)2.50
Price to Sales (P/S)1.49
P/FCF Ratio11.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)72.8
Revenue Forecast (FY)₹59.96B
Sharda Cropchem Ltd. Business Overview & Revenue Model
Company Description
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth re...
How the Company Makes Money
Sharda Cropchem primarily makes money by selling crop protection products (agrochemicals) in domestic and international markets. Its revenue model is centered on (1) obtaining and holding regulatory registrations for off-patent/generic active ingr...
Sharda Cropchem Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.72B | 52.68B | 43.20B | 31.61B | 40.45B | 35.76B |
| Gross Profit | 14.30B | 14.99B | 12.92B | 8.18B | 11.84B | 10.76B |
| EBITDA | 8.54B | 10.51B | 6.13B | 3.43B | 6.99B | 7.25B |
| Net Income | 4.52B | 6.81B | 3.04B | 318.83M | 3.42B | 3.49B |
Balance Sheet | ||||||
| Total Assets | 49.03B | 57.80B | 47.25B | 40.38B | 43.51B | 37.43B |
| Cash, Cash Equivalents and Short-Term Investments | 7.83B | 5.81B | 5.57B | 3.74B | 2.13B | 1.96B |
| Total Debt | 39.57M | 0.00 | 77.60M | 183.00M | 29.65M | 466.48M |
| Total Liabilities | 22.27B | 26.43B | 22.24B | 18.01B | 21.18B | 18.30B |
| Stockholders Equity | 26.75B | 31.36B | 25.01B | 22.37B | 22.32B | 19.12B |
Cash Flow | ||||||
| Free Cash Flow | 6.05B | 6.78B | 6.03B | 692.08M | 842.03M | 333.12M |
| Operating Cash Flow | 6.05B | 6.79B | 6.04B | 3.41B | 3.28B | 2.67B |
| Investing Cash Flow | -5.24B | -5.37B | -5.10B | -3.93B | -1.45B | -2.08B |
| Financing Cash Flow | -593.39M | -1.17B | -679.32M | -369.10M | -971.01M | -909.56M |
Sharda Cropchem Ltd. Technical Analysis
Negative
855.20
Price Trends
1032.01
Negative
1011.81
Negative
951.15
Negative
Market Momentum
-31.47
Positive
35.12
Neutral
5.57
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHARDACROP, the sentiment is Negative. The current price of 855.2 is below the 20-day moving average (MA) of 1076.30, below the 50-day MA of 1032.01, and below the 200-day MA of 951.15, indicating a bearish trend. The MACD of -31.47 indicates Positive momentum. The RSI at 35.12 is Neutral, neither overbought nor oversold. The STOCH value of 5.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SHARDACROP.
Sharda Cropchem Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹80.41B | 11.53 | ― | 1.02% | 21.94% | 123.70% | |
71 Outperform | ₹52.49B | 33.24 | ― | 0.17% | -0.75% | -2.74% | |
64 Neutral | ₹48.27B | -69.07 | ― | 0.92% | 8.79% | 46.91% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹194.13B | 53.52 | ― | 1.57% | 7.73% | 28.75% | |
60 Neutral | ₹535.84B | 25.45 | ― | 0.77% | 11.15% | 127.12% | |
55 Neutral | ₹440.49B | 39.45 | ― | 0.49% | -15.85% | -20.44% |
* Basic Materials Sector Average
IN:SHARDACROP
Sharda Cropchem Ltd.
891.30
266.03
42.55%
IN:BAYERCROP
Bayer Cropscience India Limited
4,319.65
-695.57
-13.87%
IN:DHANUKA
Dhanuka Agritech Limited
1,151.55
-473.52
-29.14%
IN:PIIND
PI Industries Limited
2,903.35
-793.44
-21.46%
IN:RALLIS
Rallis India Limited
248.20
-29.77
-10.71%
IN:UPL
UPL Limited
634.75
2.39
0.38%
Sharda Cropchem Ltd. Corporate Events
Sharda Cropchem to Hold Virtual Investor Meeting on March 10, 2026
Mar 4, 2026
Sharda Cropchem Ltd. has announced that its officials will participate in an analyst and institutional investor group meeting organized by Arihant Capital on March 10, 2026, to be held virtually between 4:00 p.m. and 5:00 p.m. The discussion will ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.